Why the study?
Optimal LV lead placement in CRT is limited by the inability to measure QLV non-invasively before implantation.
Can a standard 12-lead ECG and generic heart model accurately estimate QLV non-invasively in patients with LBBB undergoing CRT?
Population
135 standard CRT recipients
Comparison
Non-invasively estimated QLV vs measured procedural QLV
Design
Validation study using procedural recordings and forward ECG modeling
Authors
Loading...
May support pre-procedural CRT planning in LBBB; leaves open outcome benefits pending prospective validation.
Can a standard 12-lead ECG and generic heart model accurately estimate QLV non-invasively in patients with LBBB undergoing CRT?
A novel non-invasive method using a standard 12-lead ECG and generic heart model can accurately estimate QLV, potentially aiding in pre-procedural planning for optimal LV lead placement in CRT.
Melgaard et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: